The Danish Medicines Agency has given its recommendation for further development of the SoftOx inhalation solution for the treatment of respiratory infections, including COVID-19.
The SoftOx Inhalation Project aims to develop an inhalation solution for the treatment of respiratory infections. This has the potential to be a breakthrough in the treatment of...
Highlights for Q3 2020
• Annual group sales exceed 100 MNOK for the first time
• Gross profit for the Group improved 65% to NOK 26.0 million (Q3 2019: NOK 15.7 million)
• ArcticZymes had Q3 sales of NOK 19.5 million growing by 63% (Q3 2019: NOK 12.0 million)
• Biotec BetaGlucans had Q3 sales of NOK 11.2 million growing by 7% (Q3 2019: NOK 10.5 million)
ABG Sundal Collier: Photocure - Q3: a solid stepping stone towards expansion
Q3 results due 10 November US recovery and EU commercialisation in the spotlight Tweaking near term ests. – DCF TP up to NOK 130 (125)
Oslo, 19 October 2020: Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today
announced five-year overall survival data from the Phase I trial evaluating UV1
as maintenance therapy in patients with non-small cell lung cancer. The results
confirm achievement of the primary endpoints of safety and tolerability and
indicate encouraging initial signals of long-term...
VACCIBODY ENTERS INTO WORLDWIDE LICENSE AND COLLABORATION AGREEMENT WITH GENENTECH, A MEMBER OF THE ROCHE GROUP, TO DEVELOP INDIVIDUALIZED NEOANTIGEN CANCER VACCINES
Vaccibody enters into worldwide, exclusive license and collaboration agreement with Genentech to develop VB10.NEO, individualized neoantigen cancer vaccines
OCTOBER 1, 2020
VACCIBODY LISTS ON OSLO...
* Norwegian Drug Delivery Platform Biotech operating within the Oslo Cancer Cluster
* Notoriously volatile norwegian small cap with large amount of stock held by enthusiastic retail investor crowd.
* Ongoing research collaboration with AstraZeneca recently concluded, longs betting on partnership deal incoming.
* Stock typically rallies ahead of quarterly reports...
Retail longs caught offguard by huge selloff after the stock went public following its reverse merger with GRAF.
Note how hourly RSI set a lower high and other momentum indicators are about to possibly turn bullish.
NEL has become a trader favourite with recent volatility after Nikola was hit by short seller report.
Hourly 20 EMA breaking above 100 EMA, often seen as a promising momentum shift indicator.
NEL needs to break above support/resistance at about 18 and consolidate to regain a bullish sentiment in the short term.
Todays top 20 list show that the Clearstream crowd...
ONCOS-102 is one of the most promising oncolytic viruses with >200 patients treated.
Targovax stock has been under pressure for years after equity offerings at fairly low pricing, but has been making a strong move recently, quite without many investors taking notice.
Norwegian Biotech especially in the field of cancer immunotherapy may be ready for a new round of...
September 30, 2020
Bitcoin Group SE publishes semi-annual report 2020 - dynamic growth despite challenging environment
Sales revenues increase sharply by more than 153% to EUR 6,228 thousand
EBITDA more than tripled to EUR 4,177 thousand (previous year: EUR 1,231 thousand)
Management confirms all forecasts
Herford, September 30, 2020 -
Bitcoin Group SE (ISIN...
Quantafuel executed an extremely successfull round of financing after strong newsflow, but is currently trading at last relevant level of support.
Note the volume profile in the chart.
Investors could try a new long position at this price level, but should have a keen eye on risk management. Or do the safe choice, and wait to see if the stock bounces.
As expected in previous trading idea, NEL falling under important support confirmed the double top sell signal.
But NEL is a stock that has experience several huge volatility events in the past, with earlier drops from top to bottom as large as 53 and 58 %.
Compared to those the recent drop of 36% seem to not cause any sense of panic among the shareholders at...
Episurf submitted a very strong newsflow ahead of its capital markets day and the stock market reacted very positively to this.
Some cooling off is to be expected after such a strong move, but the stock is pulling back in a very calm manner and looking to establish support on top of previous highs from January.
Watch for reduced selling pressure above the 2 SEK line.
The Photocure share price has been increasing steadily even in the face of short sellers thas has been adding to their positions in Photocure stock for three weeks straight.
With the stock now trading above the last top, longs will be hoping to see a short squeeze effect in the the price development.
Recent 50SMA / 200SMA golden cross.
Top 20 ownership...
Added this very promising swedish company to my watch list. Bit late to this party, but looking to buy if the usual sell the news shenanigans occur.
Biovica develops and commercializes blood-based biomarker assays to evaluate efficacy of cancer treatments.
Biovica’s assay DiviTum® measure cell proliferation by detecting a biomarker in the blood stream. The...